See more : China Tianying Inc. (000035.SZ) Income Statement Analysis – Financial Results
Complete financial analysis of Roopa Industries Limited (ROOPAIND.BO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Roopa Industries Limited, a leading company in the Medical – Pharmaceuticals industry within the Healthcare sector.
You may be interested
- FUNR (FUNR) Income Statement Analysis – Financial Results
- Esprinet S.p.A. (0NFS.L) Income Statement Analysis – Financial Results
- Yamashin-Filter Corp. (6240.T) Income Statement Analysis – Financial Results
- Izotropic Corporation (IZOZF) Income Statement Analysis – Financial Results
- EPL Limited (EPL.NS) Income Statement Analysis – Financial Results
Roopa Industries Limited (ROOPAIND.BO)
About Roopa Industries Limited
Roopa Industries Ltd. engages in the manufacture of pharmaceutical products. Its products include triphenyl phosphine, glucosamine, and bromine and its derivatives. The company was founded on June 17, 1985 and is headquartered in Hyderabad, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 715.54M | 758.90M | 512.06M | 284.42M | 269.13M | 297.00M | 183.45M | 299.42M | 306.02M | 309.78M | 285.54M | 321.16M | 326.37M | 318.75M | 275.88M | 141.02M | 130.76M |
| Cost of Revenue | 642.58M | 619.89M | 403.15M | 176.77M | 178.77M | 231.72M | 159.51M | 189.18M | 230.36M | 204.96M | 198.82M | 217.25M | 221.92M | 227.45M | 201.11M | 91.41M | 75.81M |
| Gross Profit | 72.95M | 139.01M | 108.90M | 107.65M | 90.36M | 65.28M | 23.93M | 110.24M | 75.66M | 104.82M | 86.71M | 103.91M | 104.45M | 91.29M | 74.77M | 49.61M | 54.95M |
| Gross Profit Ratio | 10.20% | 18.32% | 21.27% | 37.85% | 33.57% | 21.98% | 13.05% | 36.82% | 24.72% | 33.84% | 30.37% | 32.36% | 32.00% | 28.64% | 27.10% | 35.18% | 42.02% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 3.01M | 2.86M | 2.65M | 1.76M | 1.32M | 3.68M | 6.07M | 2.36M | 3.56M | 5.55M | 7.46M | 0.00 | 61.80M | 48.54M | 33.39M | 0.00 |
| Selling & Marketing | 0.00 | 5.30M | 1.82M | 2.51M | 6.98M | 1.14M | 820.95K | 1.40M | 2.09M | 396.26K | 7.60M | 3.65M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 24.48M | 8.31M | 4.68M | 5.16M | 8.74M | 2.46M | 4.50M | 7.46M | 4.46M | 3.96M | 37.25M | 36.21M | 0.00 | 61.80M | 48.54M | 33.39M | 0.00 |
| Other Expenses | 0.00 | 441.00K | 134.00K | 380.00K | 805.83K | 1.47M | 27.02M | 1.66M | -184.51K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 24.64M | 105.58M | 81.76M | 87.61M | 70.27M | 45.33M | 38.02M | 86.72M | 59.34M | 88.80M | 94.46M | 93.11M | 84.60M | 79.63M | 64.98M | 44.13M | 51.03M |
| Cost & Expenses | 667.48M | 725.47M | 484.91M | 264.38M | 249.04M | 277.05M | 197.53M | 275.90M | 289.70M | 293.76M | 293.29M | 310.35M | 306.52M | 307.08M | 266.09M | 135.54M | 126.84M |
| Interest Income | 0.00 | 6.10M | 480.00K | 382.00K | 709.31K | 579.40K | 567.99K | 534.05K | 924.18K | 655.25K | 441.91K | 889.97K | 894.63K | 560.92K | 603.53K | 189.67K | 0.00 |
| Interest Expense | 26.32M | 13.63M | 10.11M | 8.76M | 9.89M | 10.30M | 7.46M | 10.69M | 8.46M | 6.37M | 5.16M | 8.22M | 4.59M | 3.06M | 4.57M | 3.68M | 0.00 |
| Depreciation & Amortization | 8.72M | 8.91M | 9.26M | 8.10M | 7.63M | 5.72M | 5.25M | 5.12M | 5.20M | 6.71M | 5.90M | 5.67M | 4.97M | 4.22M | 3.83M | 3.69M | 3.39M |
| EBITDA | 55.70M | 45.42M | 34.97M | 26.19M | 28.75M | 25.42M | 19.00M | 23.06M | 22.44M | 14.85M | -8.40M | 16.48M | 24.83M | 14.86M | 14.73M | 10.29M | 7.30M |
| EBITDA Ratio | 7.78% | 5.35% | 6.74% | 9.54% | 9.48% | 8.01% | 8.54% | 8.80% | 5.33% | 5.26% | -2.97% | 5.27% | 7.45% | 5.34% | 5.79% | 7.28% | 6.44% |
| Operating Income | 48.06M | 33.89M | 25.79M | -1.04M | 10.24M | 18.93M | -31.51M | 4.47M | 2.64M | 1.77M | -19.46M | 3.02M | 8.83M | 6.45M | 4.56M | 2.02M | 1.30M |
| Operating Income Ratio | 6.72% | 4.47% | 5.04% | -0.37% | 3.81% | 6.37% | -17.18% | 1.49% | 0.86% | 0.57% | -6.82% | 0.94% | 2.70% | 2.03% | 1.65% | 1.43% | 0.99% |
| Total Other Income/Expenses | -26.32M | -15.82M | -11.63M | -10.15M | -12.09M | -12.06M | -8.53M | -14.63M | 0.00 | -14.24M | -11.67M | -7.67M | -8.23M | 0.00 | -7.46M | -4.71M | 0.00 |
| Income Before Tax | 21.74M | 18.07M | 13.60M | 9.33M | 8.00M | 7.90M | 4.41M | 4.26M | 2.64M | 1.77M | -19.46M | 3.02M | 8.83M | 6.45M | 4.56M | 2.02M | 1.30M |
| Income Before Tax Ratio | 3.04% | 2.38% | 2.66% | 3.28% | 2.97% | 2.66% | 2.40% | 1.42% | 0.86% | 0.57% | -6.82% | 0.94% | 2.70% | 2.03% | 1.65% | 1.43% | 0.99% |
| Income Tax Expense | 6.55M | 4.57M | 3.45M | 2.16M | 4.28M | 1.86M | -984.34K | 2.38M | 929.51K | 158.12K | 605.29K | 1.27M | 2.58M | 1.61M | 1.66M | 33.96K | 305.00K |
| Net Income | 15.19M | 13.49M | 10.15M | 7.16M | 3.72M | 6.04M | 5.39M | 1.88M | 1.71M | 1.61M | -20.07M | 1.75M | 6.25M | 4.85M | 2.91M | 1.98M | 821.00K |
| Net Income Ratio | 2.12% | 1.78% | 1.98% | 2.52% | 1.38% | 2.03% | 2.94% | 0.63% | 0.56% | 0.52% | -7.03% | 0.55% | 1.91% | 1.52% | 1.05% | 1.41% | 0.63% |
| EPS | 1.95 | 1.72 | 1.29 | 0.91 | 0.47 | 0.77 | 0.69 | 0.24 | 0.22 | 0.20 | -2.55 | 0.22 | 0.88 | 0.72 | 0.43 | 0.29 | 0.12 |
| EPS Diluted | 1.95 | 1.72 | 1.29 | 0.91 | 0.47 | 0.77 | 0.69 | 0.24 | 0.22 | 0.20 | -2.55 | 0.22 | 0.88 | 0.65 | 0.43 | 0.29 | 0.12 |
| Weighted Avg Shares Out | 7.79M | 7.87M | 7.87M | 7.87M | 7.87M | 7.87M | 7.87M | 7.87M | 7.87M | 7.87M | 7.87M | 7.86M | 7.10M | 6.75M | 6.74M | 6.74M | 6.84M |
| Weighted Avg Shares Out (Dil) | 7.79M | 7.87M | 7.87M | 7.87M | 7.87M | 7.87M | 7.87M | 7.87M | 7.87M | 7.87M | 7.87M | 7.86M | 7.10M | 7.51M | 6.74M | 6.74M | 6.84M |
No news found for: ROOPAIND.BO
Source: https://incomestatements.info
Category: Stock Reports